| Rank | Ticker | Price | Market Cap | Analyst Rating | Avg Volume |
|---|---|---|---|---|---|
#1 | KYIV | $11.62 | $3.1B | Strong Buy | $834.1K |
#2 | CVSA | $113.17 | $3.9B | Strong Buy | $268.4K |
#3 | MMED | $14.30 | $4.4B | Strong Buy | $783.9K |
#4 | MDA | $31.24 | $3.8B | Strong Buy | $756.4K |
#5 | LYFT | $13.59 | $5.1B | Buy | $13.4M |
#6 | KRG | $25.41 | $5.0B | Buy | $1.4M |
#7 | BXP | $53.46 | $8.2B | Buy | $1.9M |
#8 | VICR | $186.30 | $8.1B | Strong Buy | $713.8K |
#9 | TGTX | $33.85 | $4.9B | Strong Buy | $2.1M |
#10 | PARR | $65.70 | $3.2B | Buy | $1.5M |
#11 | GWRE | $124.21 | $10.0B | Buy | $1.1M |
#12 | MTRN | $167.32 | $2.6B | Buy | $188.1K |
#13 | SIG | $92.85 | $4.0B | Buy | $967.4K |
#14 | GEO | $17.68 | $2.2B | Strong Buy | $1.9M |
#15 | DBD | $84.97 | $2.5B | Strong Buy | $574.6K |
#16 | CARG | $34.84 | $3.3B | Buy | $1.1M |
#17 | IVT | $31.81 | $2.4B | Buy | $373.5K |
#18 | WAY | $22.12 | $4.8B | Strong Buy | $2.0M |
#19 | SON | $54.97 | $4.7B | Buy | $745.2K |
#20 | SMG | $61.88 | $3.5B | Buy | $919.7K |
#21 | CSTM | $30.36 | $3.4B | Strong Buy | $2.2M |
#22 | TMDX | $113.39 | $3.4B | Buy | $951.8K |
#23 | BCRX | $9.42 | $2.1B | Strong Buy | $6.3M |
#24 | FAF | $62.91 | $6.3B | Strong Buy | $1.1M |
#25 | PAGP | $23.56 | $4.7B | Buy | $1.7M |
#26 | DUOL | $93.67 | $8.4B | Buy | $1.6M |
#27 | SHAK | $100.47 | $3.5B | Buy | $1.1M |
#28 | VRRM | $14.90 | $2.1B | Buy | $1.7M |
#29 | CALM | $75.88 | $4.0B | Buy | $995.4K |
#30 | MYRG | $320.18 | $3.9B | Buy | $243.0K |
#31 | FRSH | $7.88 | $2.3B | Buy | $4.8M |
#32 | RGEN | $122.77 | $6.6B | Buy | $768.4K |
#33 | CECO | $66.95 | $2.2B | Strong Buy | $516.3K |
#34 | PTCT | $70.50 | $5.7B | Buy | $826.3K |
#35 | DAN | $36.65 | $3.3B | Buy | $1.1M |
#36 | RELY | $17.30 | $3.3B | Buy | $2.5M |
#37 | GPOR | $197.55 | $3.8B | Buy | $266.0K |
#38 | NTNX | $37.39 | $9.1B | Buy | $3.3M |
#39 | KNSA | $47.26 | $3.5B | Strong Buy | $534.9K |
#40 | QTWO | $48.00 | $3.1B | Buy | $556.7K |
#41 | VIAV | $41.50 | $7.7B | Strong Buy | $5.9M |
#42 | PACS | $33.84 | $5.3B | Strong Buy | $679.9K |
#43 | EYE | $24.91 | $2.1B | Strong Buy | $1.3M |
#44 | ESE | $315.56 | $5.2B | Strong Buy | $297.3K |
#45 | FRPT | $68.14 | $2.9B | Buy | $1.9M |
#46 | DOCN | $79.98 | $8.5B | Buy | $5.2M |
#47 | INSP | $54.90 | $2.2B | Buy | $974.1K |
#48 | LEVI | $22.29 | $8.7B | Strong Buy | $2.9M |
#49 | GBTG | $5.70 | $2.9B | Buy | $1.4M |
#50 | KD | $13.03 | $2.8B | Buy | $3.1M |
The FinQuota filters have identified what they believe to be the "Best Mid Cap Stocks to Buy (14 April 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.